January 2011 in “Medicina interna de México” This article explains the characteristics, diagnosis, and causes of telogen effluvium hair loss but reports no new clinical findings.
This study found a high prevalence of telogen effluvium among patients hospitalized for severe COVID-19, with most experiencing early onset and eventual complete hair regrowth.
18 citations
,
March 2016 in “Cosmetics” This review discusses telogen effluvium, including its triggers, clinical presentations, and management options, and does not report new research findings, emphasizing the need for identification and exclusion of underlying causes.
November 2022 in “DOAJ (DOAJ: Directory of Open Access Journals)” This case report describes a 39-year-old hypertensive and obese patient experiencing telogen effluvium potentially linked to a previous moderate COVID-19 infection, emphasizing the need for awareness of late symptoms associated with the disease.
This review discusses the complex diagnosis and management of telogen effluvium, noting its high prevalence, psychosocial impact, and need for quantitative diagnostic techniques, but it reports no new research findings.